Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.5.2 to v3.5.3, indicating a software update to the page. It updates the version identifier displayed to users.
    Difference
    0.0%
    Check dated 2026-04-30T16:50:47.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed on the page, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:35:23.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:28:24.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T12:40:07.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding status notice and Revision: v3.4.1; these are footer/system-level updates that do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:39:45.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a government funding lapse notice indicating the NIH Clinical Center is open and where to check status. Updated site version to v3.4.1 and removed v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T23:50:27.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.